Skip to main content

Advertisement

Table 4 Average costs for each phase of sarcoma management by group (in €, 2009)

From: Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

Phases of treatment All patients CPG (+) CPG (-) p
Diagnosis overall 3,701 (7420) 4,536 (8,908) 2,728 (5,095) 0.07
  hospitalization 3,275 (7,376) 4,097 (8,791) 2,317 (4,701) 0.07
  imaging 259 (198) 274 (210) 241 (182) 0.21
  biopsy 93 (57) 88 (45) 99 (69) 0.15
  consultation 74 (96) 77 (88) 71 (105) 0.64
Surgery overall 8,170 (7,364) 7,397 (6,034) 9,075 (8,639) 0.09
  hospitalization 7,927 (7,101) 7,163 (5,773) 8,821 (8,363) 0.09
  imaging 95 (163) 108 (179) 80 (141) 0.21
  transfusion 148 (384) 126 (384) 174 (386) 0.36
Chemo-therapy overall 6,107 (11,988) 5,164 (11,197) 7,207 (13,123) 0.22
  hospitalization 3,913 (8,568) 2,938 (7,176) 5,050 (9,905) 0.07
  consultation 59 (405) 81 (545) 35 (98) 0.39
  transfusion 56 (223) 53 (228) 60 (220) 0.20
  drugs 1,956 (5,171) 1,982 (5,964) 1,925 (4,115) 0.94
  imaging 123 (279) 110 (277) 137 (284) 0.48
Radio-therapy overall 2,270 (5,850) 2,078 (5,599) 2,493 (6,173) 0.60
  hospitalization 1,544 (5,223) 1,449 (4,867) 1,656 (5,658) 0.77
  sessions 726 (1,266) 629 (1,269) 837 (1,262) 0.23
Initial treatment 20,248 (18,474) 19,175 (17,555) 21,502 (19,778) 0.36
Follow Up 5,048 (11,760) 4,396 (12,343) 5,811 (11,116) 0.38
Overall management 25,296 (22,919) 23,571 (21,913) 27,313 (24,403) 0.23